Attended IMU 'roadshow' in Perth Friday and directly asked CEO when Lag-3 (lag3 vax - in their presentation) combo likely to happen.
Response was (paraphrased) not in the short term, primarily as combo trial would be for 2 unapproved (not yet registered FDA/EMA) drugs, however, that could change quickly upon either or both being approved. Thats why combo trials are with currently approved 'blockbuster' drugs. EG - Keytruda.
Follow-up comment from CEO, 'big admirer of that company' and a friend of Marc Voight.
IMO - an important endorsement of IMM from a leader in immuno-oncology biotech industry (ex Roche - several drug approvals bench to bedside).....serious biotech players watching Immutep closely me thinks....
Media, page-379
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |